Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients by Rubio‐Viqueira, B, Hidalgo, M

Get full text

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer by Garrido-Laguna, I, Tan, A C, Uson, M, Angenendt, M, Ma, W W, Villaroel, M C, Zhao, M, Rajeshkumar, N V, Jimeno, A, Donehower, R, Iacobuzio-Donahue, C, Barrett, M, Rudek, M A, Rubio-Viqueira, B, Laheru, D, Hidalgo, M

Get full text

Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer by Weekes, Colin D, Song, Dongweon, Arcaroli, John, Wilson, Lora A, Rubio-Viqueira, Belen, Cusatis, George, Garrett-Mayer, Elizabeth, Messersmith, Wells A, Winn, Robert A, Hidalgo, Manuel

Get full text

P04.07 Relapse in a paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab by Gómez Vicente, L., Rubio Viqueira, B., Jimenez de las Peñas, M., Garcia Cobos, R., Pardo Moreno, J., Arroyo Gonzalez, R.

Get full text

Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents by JIMENO, Antonio, RUBIO-VIQUEIRA, Belen, AMADOR, Maria L, OPPENHEIMER, Darin, BOURAOUD, Nadia, KULESZA, Peter, SEBASTIANI, Valeria, MAITRA, Anirban, HIDALGO, Manuel

Get full text

PD2.02 Pembrolizumab plus Pemetrexed-Platinum for Patients with Metastatic Nonsquamous NSCLC and Liver or Brain Metastases: Results from KEYNOTE-189 by Garassino, M.C., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., De Angelis, F., Domine, M., Clingan, P., Hochmair, M.J., Powell, S.F., Cheng, S.Y.-S., Bischoff, H.G., Peled, N., Grossi, F., Jennens, R.R., Reck, M., Hui, R., Garon, E.B., Boyer, M., Rubio-Viqueira, B., Novello, S., Kurata, T., Gray, J.E., Cardellino, A., Yang, J., Pietanza, M.C., Rodríguez-Abreu, D.

Get full text

Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NS... by Gandhi, Leena, Rodgríguez-Abreu, Delvys, Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, Angelis, Flávia De, Domine, Manuel, Clingan, Philip, Hochmair, Maximilian J, Powell, Steven, Cheng, Susanna Yee-Shan, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Hui, Rina, Garon, Edward B, Boyer, Michael, Rubio-Viqueira, Belén, Novello, Silvia, Kurata, Takayasu, Gray, Jhanelle E, Vida, John J, Wei, Ziwen, Yang, Jing, Raftopoulos, Harry, Pietanza, M. Catherine, Garassino, Marina C

Get full text

Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and Survival by SEBASTIANI, Valeria, RICCI, Francesca, RUBIO-VIQUIERA, Belen, KULESZA, Piotr, YEO, Charles J, HIDALGO, Manuel, KLEIN, Alison, LAHERU, Daniel, IACOBUZIO-DONAHUE, Christine A

Get full text

Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platin... by Garassino, Marina C., Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, Speranza, Giovanna, Angelis, Flávia De, Domine, Manuel, Clingan, Philip, Hochmair, Maximilian J., Powell, Steven F., Cheng, Susanna Y.-S., Bischoff, Helge G., Peled, Nir, Grossi, Francesco, Jennens, Ross R., Reck, Martin, Hui, Rina, Garon, Edward B., Boyer, Michael, Rubio-Viqueira, Belén, Novello, Silvia, Kurata, Takayasu, Gray, Jhanelle E., Cardellino, Anna, Yang, Jing, Pietanza, M. Catherine, Rodríguez-Abreu, Delvys

Get full text